0001077183-19-000029.txt : 20190305
0001077183-19-000029.hdr.sgml : 20190305
20190305165909
ACCESSION NUMBER: 0001077183-19-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McKenzie Kathryn B
CENTRAL INDEX KEY: 0001720001
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 19659304
MAIL ADDRESS:
STREET 1: 12780 WESTLINKS DRIVE
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wf-form4_155182313355816.xml
FORM 4
X0306
4
2019-03-01
0
0001077183
NEOGENOMICS INC
NEO
0001720001
McKenzie Kathryn B
12701 COMMONWEALTH DRIVE
SUITE 9
FORT MYERS
FL
33913
0
1
0
0
Principal Accounting Officer
Common Stock
2019-03-01
4
A
0
2273
0
A
2273
D
Stock Option (Right to Buy)
19.6
2019-03-01
4
A
0
13894
19.60
A
2020-03-01
2024-03-01
Common Stock
13894.0
13894
D
Stock Option (Right to Buy)
8.03
2019-02-26
2023-02-26
Common Stock
48000.0
48000
D
Stock Option (Right to Buy)
9.07
2018-10-18
2022-10-18
Common Stock
25000.0
25000
D
On March 1, 2019, Ms. McKenzie was granted an option to purchase 13,894 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
/s/ Kathryn McKenzie
2019-03-05